Correlation Between Ikena Oncology and Prime Medicine,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ikena Oncology and Prime Medicine, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ikena Oncology and Prime Medicine, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ikena Oncology and Prime Medicine, Common, you can compare the effects of market volatilities on Ikena Oncology and Prime Medicine, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ikena Oncology with a short position of Prime Medicine,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ikena Oncology and Prime Medicine,.

Diversification Opportunities for Ikena Oncology and Prime Medicine,

0.23
  Correlation Coefficient

Modest diversification

The 3 months correlation between Ikena and Prime is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Ikena Oncology and Prime Medicine, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Prime Medicine, Common and Ikena Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ikena Oncology are associated (or correlated) with Prime Medicine,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Prime Medicine, Common has no effect on the direction of Ikena Oncology i.e., Ikena Oncology and Prime Medicine, go up and down completely randomly.

Pair Corralation between Ikena Oncology and Prime Medicine,

Given the investment horizon of 90 days Ikena Oncology is expected to generate 0.3 times more return on investment than Prime Medicine,. However, Ikena Oncology is 3.31 times less risky than Prime Medicine,. It trades about -0.01 of its potential returns per unit of risk. Prime Medicine, Common is currently generating about -0.18 per unit of risk. If you would invest  170.00  in Ikena Oncology on August 31, 2024 and sell it today you would lose (1.00) from holding Ikena Oncology or give up 0.59% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Ikena Oncology  vs.  Prime Medicine, Common

 Performance 
       Timeline  
Ikena Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ikena Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Ikena Oncology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Prime Medicine, Common 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Prime Medicine, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Etf's primary indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the fund shareholders.

Ikena Oncology and Prime Medicine, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ikena Oncology and Prime Medicine,

The main advantage of trading using opposite Ikena Oncology and Prime Medicine, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ikena Oncology position performs unexpectedly, Prime Medicine, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prime Medicine, will offset losses from the drop in Prime Medicine,'s long position.
The idea behind Ikena Oncology and Prime Medicine, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Stocks Directory
Find actively traded stocks across global markets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings